Seno Medical Instruments, Inc. Launches Imagio(TM) Research Device.Patented Laser Opto-Acoustic Imaging Technology Expected to Save LivesSAN ANTONIO San Antonio (săn ăntō`nēō, əntōn`), city (1990 pop. 935,933), seat of Bexar co., S central Tex., at the source of the San Antonio River; inc. 1837. -- Seno Medical Instruments, Inc. will announce the introduction of a new platform technology using opto-acoustics for small animal functional imaging at the Joint Molecular Imaging Conference in Providence, Rhode Island  “Providence” redirects here. For other uses, see Providence (disambiguation). Providence is the capital and the most populous city of the U.S. , September 8-9. The Joint Molecular Imaging Conference unites medical professionals and scientists with state of the art technology. Scientists and researchers from around the world will have the opportunity to learn about the Imagio[TM] research device that uses Seno's patented laser opto-acoustic imaging technology. Janet Campbell, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Seno, recently announced a $2(M) investment by the State of Texas' Emerging Technology Fund. "Our opto-acoustic technology will be presented for the first time as a commercial product as the Imagio[TM] research device. I am pleased that Seno has the opportunity to introduce this technology to such a distinguished group of researchers. Pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. will also be able to utilize Imagio[TM] for the acceleration of cancer research and drug discovery," said Campbell. Imagio[TM] technology produces real-time color images A (digital) color image is a digital image that includes color information for each pixel. For visually acceptable results, it is necessary (and almost sufficient) to provide three samples (color channels which distinguish between benign and malignant growths for all solid tumors and is expected to be a breakthrough for cancer detection. The research device produces detailed, full-scope images of small laboratory animals, such as nude mice. The image contrast is related to both blood volume and oxygenation oxygenation /ox·y·gen·a·tion/ (ok?si-je-na´shun) 1. the act or process of adding oxygen. 2. the result of having oxygen added. status, allowing lesions to be diagnosed immediately. The new technology provides functional imaging information for cancer researchers, as well as the potential for cancer screening, diagnosis, and therapeutic treatments more humane than existing technologies. In addition to the September 9 launch of the Imagio[TM] research device, to honor Conference participants Seno will also sponsor Waterfire Providence, an award-winning fire sculpture exhibit and performance spanning three rivers Three Rivers, Que., Canada: see Trois Rivières. that serves as a moving symbol of Providence's renaissance. The event is recognized as one of "America's 100 Best" by Reader's Digest Reader's Digest U.S.-based monthly magazine. Founded by DeWitt and Lila Wallace, it was first published in 1922 as a digest of articles of topical interest and entertainment value condensed from other periodicals. . About Seno Medical Seno Medical Instruments, Inc. is a San Antonio-based medical device company founded in 2005 and focused on the earliest detection of cancer through the use of its patented opto-acoustic technology. Imagio[TM] is a product of Seno. This research device will be followed by its clinical product for the detection and diagnosis of breast cancer. Future applications will address other forms of cancer. Seno's platform technology also has potential non-cancer applications in cardiovascular and inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation disease - an impairment of health or a condition of abnormal functioning NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants; and stroke. Seno's experienced management and technical teams have been assembled to commercialize the technology, supported by a nationally recognized Scientific Advisory Committee. Please visit Seno Medical Instruments, Inc. on the web at www.senomedical.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion